ANIP
NASDAQ · Pharmaceuticals
Ani Pharmaceuticals Inc
$78.85
+2.71 (+3.56%)
Open$75.50
Previous Close$76.14
Day High$79.43
Day Low$75.00
52W High$98.55
52W Low$69.58
Volume—
Avg Volume354.9K
Market Cap1.75B
P/E Ratio16.16
EPS$5.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-53.4% upside
Current
$78.85
$78.85
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 989.90M | 703.01M | 587.23M |
| Net Income | 87.79M | 56.11M | 76.98M |
| Profit Margin | 8.9% | 8.4% | 13.1% |
| EBITDA | 226.93M | 153.11M | 125.34M |
| Free Cash Flow | — | — | 59.62M |
| Rev Growth | +40.8% | +40.8% | +23.0% |
| Debt/Equity | 1.14 | 1.14 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |